Leqembi

Researchers studying headband device for Alzheimer’s disease … Some older brains have changes in oxygen levels, neural activity … More than 2M people have inflammatory bowel disease … Feds release...

CMS proposes nixing PET scan limits, which could make it easier to access Leqembi … Here’s how diabetes impairs eye healing … Semaglutide diabetes med safe in adults over 55 … Be patient if you...

On the eve of an FDA decision, CMS has released new information about the detailed patient data that clinicians must provide to ensure Medicare coverage when prescribing Leqembi.

Nevada to allow nursing home cameras … Grand jury declines to indict nursing home resident in deadly assault … FDA panel says new data support ‘full’ approval of Alzheimer’s drug Leqembi

New trial data for lecanemab (Leqembi) supports traditional, or “full” federal approval, the agency’s advisers said Friday. The decision is a step toward possible expanded patient access.

A “healthy proportion” of surveyed neurologists have already begun prescribing the treatment, and nearly all said they planned to do so if traditional FDA approval is granted.

A relative slowing of cognitive decline continues for up to two years in patients who stop taking the recently authorized drug, clinical trial data reveal.

The Alzheimer’s Association is lobbying lawmakers to convince the Biden administration to reconsider a decision not to provide full coverage for new Alzheimer’s drugs which the organization believes...

The Veterans Health Administration will provide coverage for the recently approved drug lecanemab (Leqembi) to qualified veterans with early Alzheimer’s disease. It’s a surprise move considering...

Share of adults with long COVID symptoms declining … FDA approves new drug Leqembi to treat early Alzheimer’s disease … 1 in 4 adults with chronic pain trying cannabis for relief